Advertisement
Advertisement

CANF

CANF logo

Can-Fite BioPharma Ltd. - ADR

4.19
USD
Sponsored
-0.17
-3.90%
Jan 09, 15:51 UTC -5
Closed
exchange

After-Market

4.16

-0.03
-0.72%

CANF Earnings Reports

Positive Surprise Ratio

CANF beat 4 of 4 last estimates.

100%

Next Report

Date of Next Report
Apr 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q4 24 (Revenue/ EPS)
--
/
--

Can-Fite BioPharma Ltd. - ADR earnings per share and revenue

On --, CANF reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q-- --, Can-Fite BioPharma Ltd. - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Apr 12, 2026.
Based on -- analysts, Can-Fite BioPharma Ltd. - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement